Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 150Squamous Cell Carcinoma of Head and Neck 76Head and Neck Neoplasms 75Stomach Neoplasms 52Lung Neoplasms 52Esophageal Neoplasms 34Neoplasms 33Uterine Cervical Neoplasms 32Urinary Bladder Neoplasms 32Carcinoma, Squamous Cell 27Parkinson Disease 4, Autosomal Dominant Lewy Body 26Neoplasm Metastasis 26Small Cell Lung Carcinoma 23Breast Neoplasms 23Cholangiocarcinoma 21Carcinoma 19Ovarian Neoplasms 14Adenocarcinoma Of Esophagus 14Triple Negative Breast Neoplasms 13Pancreatic Neoplasms 13Oropharyngeal Neoplasms 13Mesothelioma, Malignant 13Adenocarcinoma 13Biliary Tract Neoplasms 12Mesothelioma 11Gallbladder Neoplasms 11Esophageal Squamous Cell Carcinoma 10Carcinoma, Transitional Cell 10Tongue Neoplasms 9Laryngeal Neoplasms 9

Interventions

Gemcitabine 4Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3selpercatinib 2tariquidar 1pralsetinib 1napabucasin 1ganitumab 1Irinotecan 1Denosumab 1Cisplatin 1Capecitabine 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Endocrine Gland Neoplasms × Cisplatin × Clear all
NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 24 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡